Apolipoprotein E: an important gene and protein to follow in laboratory medicine

G Siest, T Pillot, A Régis-Bailly… - Clinical …, 1995 - academic.oup.com
The human apolipoprotein (apo) E gene is polymorphic, with three common alleles (epsilon
2, epsilon 3, epsilon 4) coding for three isoforms (E2, E3, E4). The isoforms differ from each …

Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice

T Oster, T Pillot - Biochimica et Biophysica Acta (BBA)-Molecular and …, 2010 - Elsevier
Alzheimer's disease (AD) is a major public health concern due to longer life expectancy in
the Western countries. Amyloid-beta (Aβ) oligomers are considered the proximate effectors in …

[HTML][HTML] Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models

…, S Yu, J Jackson, N Fischer, V Koziel, T Pillot… - Nature …, 2016 - nature.com
… NS, not significantly different, *P<0.05, **P<0.01 determined by one-sample t-test versus …
P<0.05, ***P<0.001 determined by one-sample t-test versus hypothetical value of 100%. …

Soluble oligomers of amyloid-β peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway

…, B Leininger-Muller, JL Olivier, T Oster, T Pillot - Neurobiology of …, 2006 - Elsevier
… Differences between control and treated groups were analyzed using Student's t test (**P <
… Differences between control and treated groups were analyzed using Student's t test (**P < …

Molecular basis of Alzheimer's disease

…, M Pincon-Raymond, J Chambaz*, T Pillot - Cellular and Molecular …, 2000 - Springer
Despite an exponential production of data, Alzheimer's disease (AD) remains an enigma.
Unresolved questions persist in the face of the heterogeneity of this neuropathology. Recent …

[HTML][HTML] N-truncated amyloid β (Aβ) 4-42 forms stable aggregates and induces acute and long-lasting behavioral deficits

…, T Pillot, S Papot-Couturier, T Lefebvre… - Acta …, 2013 - Springer
… Differences between groups were tested with unpaired t test, one-way analysis of variance
(ANOVA) followed by Bonferroni multiple comparison, two-way ANOVA or two-way repeated …

Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid‐β oligomers

…, JL Olivier, T Pillot, T Oster - Journal of …, 2006 - Wiley Online Library
A growing body of evidence supports the notion that soluble oligomers of amyloid‐β (Aβ)
peptide interact with the neuronal plasma membrane, leading to cell injury and inducing death‐…

Ciliary neurotrophic factor cell-based delivery prevents synaptic impairment and improves memory in mouse models of Alzheimer's disease

…, R Bjerkvig, T Oster, SP Niclou, T Pillot - Journal of …, 2010 - Soc Neuroscience
The development of novel therapeutic strategies for Alzheimer's disease (AD) represents
one of the biggest unmet medical needs today. Application of neurotrophic factors able to …

Cytosolic phospholipase A2 mediates neuronal apoptosis induced by soluble oligomers of the amyloid‐β peptide

…, B Bihain, T Oster, JL Olivier, T Pillot - The FASEB …, 2005 - Wiley Online Library
Recent data have revealed that soluble oligomeric forms of amyloid peptide (Aβ) may be
the proximate effectors of the neuronal injury and death occurring in Alzheimer's disease (AD). …

[HTML][HTML] Microtubule-associated protein MAP1A, MAP1B, and MAP2 proteolysis during soluble amyloid β-peptide-induced neuronal apoptosis: Synergistic …

…, FTY Potin, BE Bihain, JL Olivier, T Oster, T Pillot - Journal of Biological …, 2006 - ASBMB
A growing body of evidence supports the notion that soluble oligomeric forms of the amyloid
β-peptide (Aβ) may be the proximate effectors of neuronal injuries and death in the early …